Sponsor Pipeline

Astellas Institute for Regenerative Medicine Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07734064 A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With… Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT03167203 A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With… Macular Degenerative Disease Enrolling by Invitation
Phase 1
NCT03178149 A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their… Age-Related Macular Degeneration Recruiting
NCT07734064 A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With… Stargardt Disease Not Yet Recruiting
Get alerts when Astellas Institute for Regenerative Medicine's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free